Scientists reverse diabetes in mice with lab-grown insulin cells

Science News from research organizations Scientists reverse diabetes in mice with lab-grown insulin cells Date: May 6, 2026 Source: Karolinska Institutet Summary: Scientists in Sweden have taken a major step toward a potential cure for type 1 diabetes by developing a more reliable way to create insulin-producing cells from human stem cells. These lab-grown cells not only respond strongly to glucose but were also able to restore blood sugar control when transplanted into diabetic mice. Share: Facebook Twitter Pinterest LinkedIN Email FULL STORY

New Cells Reverse Diabetes in Mice — Scientists may be closing in on a stem cell–based cure for type 1 diabetes after reversing the disease in mice. Credit: Shutterstock

Scientists in Sweden have developed a more reliable way to create insulin-producing cells from human stem cells, bringing new momentum to efforts to treat type 1 diabetes. The research, published in Stem Cell Reports, shows that these lab-grown cells can effectively control blood sugar in tests and even reverse diabetes in mice.

Type 1 diabetes develops when the immune system attacks and destroys the pancreas's insulin-producing cells. Without insulin, the body cannot properly absorb glucose from the bloodstream, leading to dangerous blood sugar levels. Replacing these lost cells has long been seen as a promising solution, but earlier attempts to grow them from stem cells have produced inconsistent results.

"We have developed a method that reliably produces high-quality insulin-producing cells from multiple human stem cell lines. This opens up opportunities for future patient-specific cell therapies, which could reduce immune rejection," says Per-Olof Berggren, professor at the Department of Molecular Medicine and Surgery, Karolinska Institutet, and corresponding author alongside Siqin Wu, researcher at Spiber Technologies AB (formerly at Karolinska Institutet).

More Mature and Functional Insulin Cells

The new approach improves how these cells are produced, resulting in insulin-producing cells that are both more refined and more functional than those made with earlier techniques. In laboratory experiments, the cells released insulin and showed a strong response to glucose levels.

When transplanted into diabetic mice, the cells gradually restored the animals' ability to regulate blood sugar. The researchers placed the cells in the anterior chamber of the eye, allowing them to observe how the cells developed and functioned over time.

"This is a technique we use to monitor the development and function of the cells over time in a minimally invasive way," explains Per-Olof Berggren. "We observed that the cells gradually matured after transplantation, retaining their ability to regulate blood sugar for several months, which demonstrates their potential for future treatments."

Overcoming Long-Standing Challenges

Stem cell therapies for type 1 diabetes are already being tested in clinical trials, but they face several hurdles. One major issue has been that stem cells often turn into a mix of useful and unwanted cell types, which can increase risks. Another challenge is that lab-grown insulin cells are often not mature enough to respond effectively to glucose.

To address these problems, the researchers refined the culture process and allowed the cells to form natural three-dimensional clusters. This step reduced the number of unwanted cell types and improved how well the cells responded to glucose.

"This could solve several of the problems that have previously hindered the development of stem cell-based treatments for type 1 diabetes. Building on this, we will work towards clinical translation aiming at treating type 1 diabetes," says Fredrik Lanner, professor at the Department of Clinical Science, Intervention and Technology, Karolinska Institutet, and last author of the paper.

Toward Future Diabetes Treatments

The study was a collaboration between Karolinska Institutet and KTH Royal Institute of Technology in Sweden. Funding came from several organizations, including the Swedish Research Council, STINT, the Knut and Alice Wallenberg Foundation, the Novo Nordisk Foundation, the European Research Council's (ERC) Advanced Grant, the Erling-Persson Family Foundation, the Jonas & Christina af Jochnick Foundation, the Swedish Diabetes Association, Vinnova and Karolinska Institutet's Strategic Research Program in Diabetes. Some researchers also report ties to companies, including patent applications and employment at Spiber Technologies AB and Biocrine AB (see publication for full details).

RELATED TOPICS
- Health & Medicine

RELATED TERMS

Story Source:

Materials provided by Karolinska Institutet. Note: Content may be edited for style and length.

Journal Reference:

Siqin Wu, Shivam Chandel, Galyna Bryzgalova, Paschalis Efstathopoulos, Kelly Blust, Cheng Zhao, Eda Erbil, Anna Falk, My Hedhammar, Per-Olof Berggren, Fredrik Lanner. An optimized protocol for efficient derivation of pancreatic islets from multiple human pluripotent stem cell lines. Stem Cell Reports, 2026; 102892 DOI: 10.1016/j.stemcr.2026.102892

Cite This Page:

Karolinska Institutet. "Scientists reverse diabetes in mice with lab-grown insulin cells." ScienceDaily. ScienceDaily, 6 May 2026. <www.sciencedaily.com/releases/2026/05/260505234620.htm>. Karolinska Institutet. (2026, May 6). Scientists reverse diabetes in mice with lab-grown insulin cells. ScienceDaily. Retrieved May 6, 2026 from www.sciencedaily.com/releases/2026/05/260505234620.htm Karolinska Institutet. "Scientists reverse diabetes in mice with lab-grown insulin cells." ScienceDaily. www.sciencedaily.com/releases/2026/05/260505234620.htm (accessed May 6, 2026).

Explore More

from ScienceDaily RELATED STORIES New Molecular Mechanisms Linked to Insulin Resistance Feb. 19, 2025 Insulin resistance precedes and predicts the onset of type 2 diabetes mellitus (DM2), a chronic disease that causes high morbidity and mortality worldwide. In affected people, insulin is unable to ... Getting to the Root of the Problem: Intensive Diabetes Treatment Reduces Gum Disease Inflammation Sep. 17, 2024 A recent study reveals that intensive diabetes treatment can improve periodontal disease inflammation. Researchers found that two weeks of intensive diabetes treatment under hospitalization for ... Scientists Identify 'Missing Piece' Required for Blood Stem Cell Self-Renewal June 5, 2024 Blood stem cells -- key to transplants that are used as life-saving treatments for blood cancers and blood and immune disorders -- have the capacity to self-renew, but quickly lose their ability to ... Stem Cell-Based Treatment Controls Blood Sugar in People With Type 1 Diabetes Nov. 27, 2023 An innovative stem cell-based treatment for Type 1 diabetes can meaningfully regulate blood glucose levels and reduce dependence on daily insulin injections, according to new clinical trial ... The Beta Cell Whisperer Gene Nov. 2, 2022 Diabetes, which affects millions of people worldwide, develops when the body either generates insufficient amounts of the hormone insulin -- a hormone that maintains healthy blood sugar -- or when ... Potential Target for Type 1 Diabetes Treatment July 22, 2022 Scientists have discovered a pathway to the regeneration of insulin in pancreatic stem cells, a major breakthrough toward new therapies to treat Type 1 and Type 2 diabetes. Using the pancreas stem ... TRENDING AT SCITECHDAILY.com

Physicists Propose Strange Experiment Where Time Goes Quantum

Magnesium Magic: New Drug Melts Fat Even on a High-Fat, High-Sugar Diet

Weight-Loss Drugs Like Ozempic May Come With an Unexpected Cost

Mezcal “Worm” in a Bottle Mystery: DNA Testing Reveals a Surprise